Skip to content

Effect of Perioperative Lidocaine on Gastrointestinal Function Recovery After Lumbar Spine Surgery in Adults

Effect of Perioperative Lidocaine on Gastrointestinal Function Recovery After Lumbar Spine Surgery in Adults: a Multicenter, Randomized, Double-blind, Controlled Study

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04922359
Enrollment
96
Registered
2021-06-10
Start date
2021-06-01
Completion date
2023-05-15
Last updated
2021-06-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastrointestinal Dysfunction, Lidocaine, Opioid Consumption, Pain, Spinal Surgery

Keywords

Lidocaine, Gastrointestinal Dysfunction, Spinal surgery, Opioid consumption

Brief summary

Spinal surgery often involves multiple segments. The trauma of surgery is large, the duration of postoperative pain is long, and the pain is severe. Therefore, the use of opioids in perioperative period is large. Although the application of \* large amounts of opioids can effectively inhibit pain, it will delay the recovery of urine retention, sedation, respiratory depression and gastrointestinal function. The delayed recovery of gastrointestinal function will increase the postoperative complications, and then increase the length of hospital stay and the cost of patients. Therefore, reducing the dosage of opioids to promote the recovery of gastrointestinal function has become the research direction. Intravenous lidocaine has been proved to be effective in reducing the dosage of opioids during the perioperative period of gastrointestinal surgery and promoting the recovery of postoperative gastrointestinal function. However, there are few studies on the application of lidocaine during the perioperative period of spinal surgery, especially the impact on postoperative gastrointestinal function. In this study, a multicenter, randomized, double-blind, controlled study was conducted to explore the effect of perioperative lidocaine on the recovery of gastrointestinal function after adult lumbar surgery. We hypothesized that lidocaine could shorten the recovery time of gastrointestinal function after lumbar surgery

Interventions

DRUGLidocain

Patients received 1.5mg/kg of intravenous lidocaine during induction of anesthesia and 1.5 mg/kg/h for anesthesia maintenance.

DRUGnormal saline

Patients received 0.075ml/kg of intravenous normal saline during induction of anesthesia and 0.075ml/kg/h for anesthesia maintenance.

Sponsors

Wangjing Hospital, China Academy of Chinese Medical Sciences
CollaboratorOTHER
First Affiliated Hospital of Guangxi Medical University
CollaboratorOTHER
Peking University People's Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Caregiver)

Eligibility

Sex/Gender
ALL
Age
60 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

1. age 60 to 80; 2. ASA physical status score of I, II or III; 3. Scheduled to undergo a posterior lumbar surgery; 4. Ideal body weight≤80 kg;

Exclusion criteria

1. Those who are refused to be included; 2. Those who are allergic to the drugs used in this study; 3. Emergency operation 4. Degree II or III atrioventricular block 5. heart failure 6. History of ALS, preexcitation or active dysrhythmia 7. Severe liver injury (bilirubin \> 1.46 mg/dl) 8. Severe renal injury (creatinine clearance \< 30 ml/min) or Renal failure 9. History of epilepsy 10. History of porphyria 11. Preoperative hypotension (SBP\< 90mmHg) 12. Drug contraindications of NSAIDs 13. Allergic to anaesthetic

Design outcomes

Primary

MeasureTime frameDescription
First anal exhaust timeDay 0Time of first anal exhaust after operation

Secondary

MeasureTime frameDescription
First defecation timeDay 0Time of first defecation after operation
First diet timeDay 0Time of first feeding after operation
Time to get out of bedDay 0Time to get out of bed after operation

Countries

China

Contacts

Primary ContactJie Gu, attending
hmugujie@163.com15210886376

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026